Literature DB >> 11013984

[Possibilities and limits of conservative therapy of spondylitis and spondylodiscitis].

C H Flamme1, T Frischalowski, F Gossé.   

Abstract

BACKGROUND AND AIM OF THE STUDY: For many years the treatment of spondylitis and spondylodiscitis has been discussed controversially. The aim of this study is to report on objective and subjective mid-term results of therapy of spondylitis and to present a differentiated concept of treatment.
METHODS: Between 1988 and 1996, 58 patients were treated with spondylitis or spondylodiscitis. Nine of these patients had to be operated. A biopsy was taken in all of the cases. According to the antibiogram obtained by the biopsy, antibiotics were applied intravenously. The patients were immobilized by a plaster bed for at least 6 weeks and were then treated by a spinal orthosis for another 3 months. Patients were re-examined clinically and radiographically and by a questionnaire (including Roland-Morris score), after 8 years on average.
RESULTS: Patients were diagnosed correctly 4 months after the begin of the disease. Spondylitis was predominantly localized in the lumbar spine. A positive bacteriological culture was derived from one third of the biopsies; none of them was a specific culture. C-reactive protein was revealed as appropriate for diagnosis and follow-up of spondylitis. In 84% of the patients a total or partial bony fusion was demonstrated radiographically. Questionnaire assessment revealed a significant decrease of the Roland-Morris score (17.8-7.4) and a significant relief of pain (8.9-2.5).
CONCLUSIONS: We recommend surgical treatment on patients with major vertebral body destruction, epidural abscess and progressive neurological impairment. These indications for operation can be prevented by a rapid diagnosis, so that spondylitis can be successfully treated by consequent immobilization in a plaster bed and appropriate antibiotics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11013984     DOI: 10.1007/s003930070065

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  3 in total

Review 1.  Treatment of spondylodiscitis.

Authors:  Kourosh Zarghooni; Marc Röllinghoff; Rolf Sobottke; Peer Eysel
Journal:  Int Orthop       Date:  2011-12-06       Impact factor: 3.075

2.  [Spondylodiscitis after perioperative peridural catheter].

Authors:  M Müller; C Burger; J Andermahr; K Mader; C Rangger
Journal:  Anaesthesist       Date:  2004-12       Impact factor: 1.041

3.  [Pyogenic spondylodiscitis: therapy algorithm and a new classification for therapeutic decision-making].

Authors:  M Akbar; R Sobottke; B Lehner; M Eichler; H Wang; C Carstens; B Wiedenhöfer
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.